THE CLINICAL IMPACT OF NEPHROTOXICITY IN LIVER TRANSPLANTATION

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Transplantation

• Publication date

  2000-06-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-200006271-00005PMID 10910259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunosuppressant-Induced Nephropathy

  1999cited by this paper
• Sirolimus: a potent new immunosuppressant for liver transplantation.

  1999cited by this paper
• Mycophenolate mofetil monotherapy in stable liver transplant patients with cyclosporine-induced renal impairment: a preliminary report.

  1999cited by this paper
• Progress with cyclosporine-sparing regimens.

  1999cited by this paper
• Chronic renal failure following liver transplantation: a retrospective analysis.

  1998cited by this paper
• Risk factors for acute renal failure requiring dialysis after liver transplantation

  1998cited by this paper
• The side-effects of ciclosporine-A and tacrolimus.

  1998cited by this paper
• Immunophilins: beyond immunosuppression.

  1998cited by this paper
• Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.

  1998cited by this paper
• Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine.

  1996cited by this paper
• Hemolytic uremic syndrome in solid-organ transplant recipients

  1996cited by this paper
• Cyclosporin A: Drug discontinuation for the management of long‐term toxicity after liver transplantation

  1996cited by this paper
• Renal transplantation: current status, complications and prevention.

  1995cited by this paper
• IMPACT OF PRETRANSPLANT RENAL FUNCTION ON SURVIVAL AFTER LIVER TRANSPLANTATION

  1995cited by this paper
• Renal Insufficiency and Hypertension as Long-Term Complications in Liver Transplantation

  1995cited by this paper
• Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.

  1994cited by this paper
• Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection

  1994cited by this paper
• Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.

  1994cited by this paper
• A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.

  1994cited by this paper
• Blood cyclosporin concentrations but not doses correlate with acute changes in renal function following heart and heart-lung transplantation.

  1992cited by this paper
• Acute and chronic renal failure in liver transplantation.

  1990cited by this paper
• Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.

  1988cited by this paper
• Effects of renal impairment on liver transplantation.

  1987cited by this paper
• Renal histopathologic alterations in patients treated with cyclosporine for uveitis.

  1986cited by this paper

• Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study

  2016cites this paper
• Renal function and histology in children after small bowel transplantation

  2013cites this paper
• Electrolyte free water clearance could be an early sign of renal dysfunction in renal transplant patients.

  2009cites this paper
• Nephrotoxicity as a cause of acute kidney injury in children

  2008cites this paper
• An Experience From China of Perioperative Care in 1510 Liver Transplant Recipients

  2006cites this paper
• Experience with cyclosporine.

  2004cites this paper
• Sirolimus and mycophenolate mofetil after liver transplantation

  2003cites this paper
• Health‐related quality of life in pediatric liver transplant recipients: A single‐center study

  2003cites this paper
• Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long‐term study

  2002cites this paper
• Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study

  2002cites this paper
• Predictors of renal function following lung or heart-lung transplantation.

  2002cites this paper
• Identification of patients best suited for combined liver–kidney transplantation: Part II

  2002cites this paper
• [Renal insufficiency in liver transplantation].

  2002cites this paper
• Cyclosporin A Toxicity of the Renal Allograft – a Late Complication and Potentially Reversible

  2002cites this paper
• Long‐term outcome after liver transplantation in children

  2002cites this paper
• mTOR inhibitors: An overview

  2001cites this paper
• Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

  2001cites this paper
• Late mortality after orthotopic liver transplantation.

  2001cites this paper